Table 2 Efficacy of re-treatment with pemetrexed-based chemotherapy in 30 patients affected by malignant mesothelioma
From: Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
| Â | N. (%) |
|---|---|
N. of patients | 30 (100) |
Regimen of re-treatment: | Â |
---Pemetrexed | 9 (30) |
---Cisplatin + pemetrexed | 5 (17) |
---Carboplatin + pemetrexed | 16 (53) |
Response: | Â |
---Stable disease | 15 (50) |
---Partial response | 5 (17) |
---Disease progression | 10 (33) |
Performance Status | Â |
---0 | 0 |
---1 | 21 (70) |
---2 | 9 (30) |
Symptom palliation: | Â |
---Worsening | 10 (33) |
---Absence of pain (before treatment and after) | 7 (23) |
---Pain reduction | 13 (43) |